NASDAQ · CEROW
CERo Therapeutics Holdings, Inc.
Healthcare · Biotechnology
$0.00
Up+$0.00 (+0.00%)
Updated Aug 17, 2026, 9:39 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 158.75K
- P/E ratio
- -0.01
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 350
- Avg. volume
- 114.57K
Price performance
CEROW price history
1M range · 0 trading sessions · Daily adjusted prices
CEROW does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest CEROW news
The latest Smart Investors Daily articles mentioning CEROW.
Stock researchCompany · Overview
CEROW research
Overview
Company profile and research snapshot.
Company profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
